Health technology company GenomOncology expands its board

Cleveland health care technology company GenomOncology LLC announced that it has added Jonathan Seaton, former senior vice president for corporate and business development at Illumina Inc. (Nasdaq: ILMN), to its board of directors.

The addition of Seaton gives GenomOncology a total of six board members. In a news release, Brad Wertz, the executive chairman of GenomOncology, said Seaton will “provide critical guidance for the road ahead” for the company, which has developed a technology platform to streamline the use of next-generation sequencing data in medical care and research.

Click here to read the complete article.

Story excerpt provided by Crain’s Cleveland Business.

Originally published September 25, 2018.